-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SAR-BBN in Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SAR-BBN in Metastatic Castration-Resistant Prostate Cancer (mCRPC) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. SAR-BBN in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Drug...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Influenza [Strains A/H1N1 + A/H3N2 + B/Victoria + B/Yamagata] (Quadrivalent, Split Virion) Vaccine in Seasonal Influenza
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Influenza [Strains A/H1N1 + A/H3N2 + B/Victoria + B/Yamagata] (Quadrivalent, Split Virion) Vaccine in Seasonal Influenza report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical...
-
Product Insights
Seasonal Influenza Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2024 Update
Seasonal Influenza Clinical Trial Report Overview A total of 310 seasonal influenza clinical trials were conducted as of February 2024. The Seasonal Influenza clinical trial report provides a comprehensive understanding of the seasonal influenza clinical trial scenario across regions, and countries (G7 & E7), along with insights into the various phases, trial status, and end points status. The report also includes information about the sponsor types and the prominent sponsors associated with the trials. Key Regions ·       North America ·       ...
-
Product Insights
NewNeisseria meningitidis Infections – Drugs In Development, 2024
Empower your strategies with our Neisseria meningitidis Infections – Drugs In Development, 2024 report and make more profitable business decisions. Neisseria Meningitidis is a severe bacterial infection of the bloodstream and meninges (a thin lining covering the brain and spinal cord). Symptoms include fever, neck stiffness, joint pain, nausea, confusion and drowsiness. Risk factors include age, smoking, mucosal lesions, overcrowding, climatic conditions such as dry seasons or prolonged drought and dust storms and concomitant respiratory infections. The Neisseria meningitidis Infections drugs...
-
Product Insights
NewRotavirus Infections – Drugs In Development, 2024
Empower your strategies with our Rotavirus Infections – Drugs In Development, 2024 report and make more profitable business decisions. Rotavirus is a virus that infects the bowels. Rotavirus is the most common cause of severe diarrhea among infants and children. Transmission of rotavirus most often occurs through fecal-oral contact. Usually, this occurs from poor hand washing or from ingestion of contaminated food or water. The virus may also be transmitted through the respiratory tract or by other body fluids, but these...
-
Product Insights
NewSeasonal Influenza – Drugs In Development, 2024
Empower your strategies with our Seasonal Influenza – Drugs In Development, 2024 report and make more profitable business decisions. Seasonal influenza, commonly referred to as "the flu", is a contagious respiratory illness caused by influenza viruses. It typically occurs in outbreaks during the fall and winter months, peaking between December and February in the Northern Hemisphere. The flu can cause mild to severe illness and, in some cases, can lead to hospitalization or even death, especially among vulnerable populations. Symptoms of...
-
Product Insights
NewTetanus – Drugs In Development, 2024
Empower your strategies with our Tetanus – Drugs In Development, 2024 report and make more profitable business decisions. Tetanus is a serious illness caused by Clostridium bacteria. Signs and symptoms of tetanus include spasms and stiffness in jaw muscles, difficulty swallowing, stiffness of abdominal muscles, fever, sweating, elevated blood pressure, and rapid heart rate. The predisposing factors include burns, surgical wounds, ear infections, swelling around the injury, and infected foot ulcers. Treatment includes antibiotics, sedatives, and beta blockers. The Tetanus drugs...
-
Product Insights
NewLeukocyte Disorders (White Blood Cell Disorders) – Drugs In Development, 2024
Empower your strategies with our Leukocyte Disorders (White Blood Cell Disorders) – Drugs In Development, 2024 report and make more profitable business decisions. Leukocyte disorders, also known as white blood cell disorders, encompass a range of conditions that involve abnormalities in the production, function, or levels of white blood cells (leukocytes). White blood cells play a crucial role in the immune system, defending the body against infections, diseases, and foreign invaders. The Leukocyte Disorders (White Blood Cell Disorders) drugs in development...
-
Product Insights
NewRubella (German Measles) – Drugs In Development, 2024
Empower your strategies with our Rubella (German Measles) – Drugs In Development, 2024 report and make more profitable business decisions. Rubella, also known as German measles, is an acute, contagious viral infection. The rubella virus is transmitted by airborne droplets when infected people sneeze or cough. Symptoms include fever, headache, stuffy or runny nose, red and inflamed eyes, aching joints, and enlarged, tender lymph nodes at the base of the skull, the back of the neck, and behind the ears. The...
-
Product Insights
NewRubivirus Infections – Drugs In Development, 2024
Empower your strategies with our Rubivirus Infections – Drugs In Development, 2024 report and make more profitable business decisions. Rubi virus Infections causes rubella and is placed in the Rubi virus genus of togaviridae family. It is a single stranded RNA virus causing infections most predominantly in children and is also known as German measles. Mode of transmission is through droplets contacts and spreads to other organs. It can also transmit from mother to fetus through placenta. In most cases it...